Evidence map›Paper›PMID 34881009›Full record

ArticleChemical science2021

Chiral exciplex dyes showing circularly polarized luminescence: extension of the excimer chirality rule.

Kazuto Takaishi, Sho Murakami, Kazuhiro Iwachido, Tadashi Ema

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Article
  3. A Bis-Perylene Diimide Macrocycle Chiroptical Switch.Angewandte Chemie (International ed. in English) · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kazuto TakaishiDivision of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University Tsushima Okayama 700-8530 Japan takaishi@okayama-u.ac.jp ema@cc.okayama-u.ac.jp.ORCID https://orcid.org/0000-0003-4979-7375
Sho MurakamiDivision of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University Tsushima Okayama 700-8530 Japan takaishi@okayama-u.ac.jp ema@cc.okayama-u.ac.jp.
Kazuhiro IwachidoDivision of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University Tsushima Okayama 700-8530 Japan takaishi@okayama-u.ac.jp ema@cc.okayama-u.ac.jp.
Tadashi EmaDivision of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University Tsushima Okayama 700-8530 Japan takaishi@okayama-u.ac.jp ema@cc.okayama-u.ac.jp.ORCID https://orcid.org/0000-0002-2160-6840

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A series of axially chiral binaphthyls and quaternaphthyls possessing two kinds of aromatic fluorophores, such as pyrenyl, perylenyl, and 4-(dimethylamino)phenyl groups, arranged alternately were synthesized by a divergent method. In the excited state, the fluorophores selectively formed a unidirectionally twisted exciplex (excited heterodimer) by a cumulative steric effect and exhibited circularly polarized luminescence (CPL). They are the first examples of a monomolecular exciplex CPL dye. This versatile method for producing exciplex CPL dyes also improved fluorescence intensity, and the CPL properties were not very sensitive to the solvent or to the temperature owing to the conformationally rigid exciplex. This systematic study allowed us to confirm that the excimer chirality rule can be applied to the exciplex dyes: left- and right-handed exciplexes with a twist angle of less than 90° exhibit (-)- and (+)-CPL, respectively.

Identifiers

PMID34881009
PMCPMC8580037

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.